temazepam (Restoril)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Restoril. DEA-controlled substance: class 4.

Indications

short-term management of transient insomnia

Contraindications

pregnancy category = x

safety in lactation = -

Dosage

15-30 mg PO QHS[1][2]

Tabs: 7.5, 15 & 30 mg.

Pharmacokinetics

elimination via kidney

1/2life = 8-25 hours

protein binding = 98 %

elimination by hemodialysis = -

Adverse effects

Drug interactions

Laboratory

Mechanism of action

More general terms

References

  1. 1.0 1.1 The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. 2.0 2.1 2.2 Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 7
  3. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  4. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  5. Clinical Guide to Laboratory Tests, NW Tietz (ed) 3rd ed, WB Saunders, Philadelpha 1995

Database